Options Update: Human Genome November...

Options Update: Human Genome November volatility at 248 into data

There are 1 comment on the Blogging Stocks story from Oct 31, 2009, titled Options Update: Human Genome November volatility at 248 into data. In it, Blogging Stocks reports that:

Human Genome closed at $19.97. HGSI's Benlysta, a lupus treatment, is expected to have phase 3 data released on November 2. HGSI November option implied volatility is at 249, December is at 170, January is at 143 and April is at 112, according to Track Data, suggesting large movement.

Join the discussion below, or Read more at Blogging Stocks.


Garden City, NY

#1 Nov 1, 2009
Research on new Benlysta lupus drug has been completed: http://www.orderonlinedrugs.com/drug-news/200...

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Human Genome Sciences Discussions

Title Updated Last By Comments
News Transcept's Intermezzo Has Significant Long Ter... (Jan '12) Oct '13 Jessamyn 8
News US adviser on board of firm that sold anthrax drug (May '13) May '13 KittenKoder 1
News GSK secures $3.6bn HGS deal (Jan '13) Jan '13 kmc2749 1
News Human Genome agrees to GlaxoSmithKline takeover (Jul '12) Jul '12 HumanSpirit 1
human genome (May '09) Jun '12 Species 2
News Human Genome rejects GlaxoSmithKline's $2.6B bid (Apr '12) Apr '12 Duh Moment 3
News Shares of Human Genome Sciences ([[HGSI]] -7.1%... (Mar '12) Mar '12 aliya 2
More from around the web